26Jul 2025
Emerging Cross-Resistance in Candida Species Threatens New Antifungal Manogepix

Emerging Cross-Resistance in Candida Species Threatens New Antifungal Manogepix

A new study reveals that Candida auris and related species may develop cross-resistance to both fluconazole and manogepix, a promising antifungal in trials. Mutations in transcriptional regulators like TAC1B and PDR1 appear to drive resistance via overexpression of drug efflux transporters such as Cdr1, raising major concerns for future treatment options.

  • #oncology

Like

Save

Share